Tekturna and Renin
Links shared publicly online about this topic
FDA approves Tekturna HCT as initial treatment in patients unlikely to achieve their blood pressure goal with a single agent
novartis.com — “Basel, July 21, 2009 - The US Food and Drug Administration (FDA) has approved Tekturna HCT (aliskiren and hydrochlorothiazide) tablets as initial therapy for patients who are likely to need multiple drugs to achieve their blood pressure goals. Tekturna HCT is a single-pill combination of Tekturna (aliskiren), the first and only approved direct renin inhibitor[1], and the diuretic hydrochlorothiazide (HCTZ), one of the most commonly used high blood pressure medications[5].” View full resource at novartis.com
Most Recently Shared on July 21, 2009 at 1:43 pm By:
eyeonfda Pharma and Health Lawyer
FDA approves Tekturna HCT® as initial treatment in pts unlikely to achieve blood pressure goal with a single agent http://bit.ly/AfNcA
Medical News: FDA Approves Diuretic Direct Renin Inhibitor Combo Pill - in Cardiovascular, Hypertension from MedPage Today
medpagetoday.com — “CLEVELAND -- The maker of the direct renin inhibitor aliskiren (Tekturna) has received FDA approval to market a polypill -- aliskiren plus hydroclorothiazide -- for initial treatment of hypertension” View full resource at medpagetoday.com
Most Recently Shared on July 21, 2009 at 9:07 pm By:
FDA Approves Diuretic Direct Renin Inhibitor Combo Pill http://ow.ly/15IptS
Medical News: ACC: Renin Inhibitor Fails to Improve Post-MI Outcomes - in Meeting Coverage, ACC from MedPage Today
medpagetoday.com — “ATLANTA -- When added to optimal medical therapy, aliskiren (Tekturna), a direct renin inhibitor, did not improve outcomes for patients who had had a myocardial infarction accompanied by left ventricu” View full resource at medpagetoday.com
Most Recently Shared on March 17, 2010 at 9:07 pm By:
ACC: Renin Inhibitor Fails to Improve Post-MI Outcomes (CME/CE) ATLANTA (MedPage Today) -- When added to optimal medi.. http://bit.ly/9vPKqX
Rasilez, first-in-class direct renin inhibitor, provides greater reduction in high blood pressure than ACE inhibitor ramipril in patients 65 and older
novartis.com — “Basel, November 11, 2008 - New clinical data presented today show first-in-class direct renin inhibitor Rasilez [*] (aliskiren), known as Tekturna in the US, provides significantly greater blood pressure reductions in patients with high blood pressure aged 65 and over, compared to the angiotensin-converting enzyme (ACE) inhibitor ramipril[1].” View full resource at novartis.com
Most Recently Shared on November 11, 2008 at 6:19 pm By:
Rasilez®, first-in-class direct renin inhibitor, provides greater reduction in high blood pressure than .. http://tinyurl.com/66erzc
Debate on aliskiren data
theheart.org — “Aliskiren, a new direct renin inhibitor, reduced blood pressure to a greater degree than one of the usually recommended first-line agents, hydrochlorothiazide, in a new study. But there are a number of criticisms of the trial, including the assertion that the diuretic is not the ideal comparator. (Schmieder RE et al. Circulation 2009; 119:417-425.)” View full resource at theheart.org
Most Recently Shared on January 19, 2009 at 4:33 pm By:
New data on aliskiren provoke debate http://tinyurl.com/a8d3u8
Novartis receives FDA approval of Tekamlo, a single-pill combination of aliskiren and amlodipine to treat high blood pressure
drugs.com — “Tekamlo (aliskiren and amlodipine) is used to treat high blood pressure. Includes Tekamlo side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on August 29, 2010 at 11:22 pm By:
FDA approves Tekamlo (aliskiren and amlodipine) to treat high blood pressure - http://bit.ly/cKmXHQ
Novartis Gains FDA Approval for Amturnide, a Triple-Combination Pill to Treat High Blood Pressure in Patients Uncontrolled on Two Medications
drugs.com — “Amturnide (aliskiren, amlodipine and hydrochlorothiazide) is used to treat high blood pressure. Includes Amturnide side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on December 29, 2010 at 8:12 pm By:
Drugs and Devices OW OW Health
Novartis Gains FDA Approval for Amturnide, a Triple-Combination Pill to Treat High Blood Pressure in Patie... http://bit.ly/fyXi8b #drug
Novartis Gains FDA Approval for Amturnide, a Triple-Combination Pill to Treat High Blood Pressure in Patients Uncontrolled on Two Medications
drugs.com — “Amturnide (aliskiren, amlodipine and hydrochlorothiazide) is used to treat high blood pressure. Includes Amturnide side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on December 29, 2010 at 7:41 pm By:
FDA Approves Amturnide, a Triple-Combination Pill to Treat High Blood Pressure - http://bit.ly/eyIMLr
Medical News: Novel Combo Pill for Hypertension Approved - in Cardiovascular, Hypertension from MedPage Today
medpagetoday.com — “Another type of combination pill for hypertension has won FDA approval -- this time putting a direct renin inhibitor together with a calcium channel blocker.” View full resource at medpagetoday.com
Most Recently Shared on August 27, 2010 at 11:00 pm By:
Hisham Rana, MD Doctor and Physician
News: Novel combo pill Tekamlo approved for high blood pressure http://bit.ly/bYZUEh - See next tweet for comment.... #health
Medical News: Novartis Pulls Plug on Aliskiren Study - in Cardiovascular, Hypertension from MedPage Today
medpagetoday.com — “Drug maker Novartis has terminated the randomized ALTITUDE study in response to increased adverse events among high-risk patients taking aliskiren (Tekturna), a direct renin inhibitor, as an add-on to” View full resource at medpagetoday.com
Most Recently Shared on December 20, 2011 at 8:14 pm By:
Novartis Pulls Plug on Aliskiren Study. http://t.co/gIz8CxOy
FDA approves Novartis' Tekamlo for treatment of high blood pressure
news-medical.net — “The US Food and Drug Administration (FDA) approved Tekamlo" (aliskiren and amlodipine) tablets, a single-pill for the treatment of high blood pressure combining the only approved direct renin inhibitor, Tekturna® (aliskiren), with the widely used calcium channel blocker amlodipine. Tekamlo is approved as initial therapy for patients who are likely to need multiple drugs to achieve their blood pressure goals, and as replacement therapy for patients whose blood pressure is not adequately cont” View full resource at news-medical.net
Most Recently Shared on August 27, 2010 at 1:18 pm By:
FDA approves Novartis' Tekamlo for treatment of high blood pressure: The US Food and Drug Administration (FDA) app... http://bit.ly/a1tO77
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
eyeonfda
Author of the blog Eye on FDA - www.eyeonfda.com
-
Medical News
unbiased curator, editor & aggregator of the latest medical and healthcare news and information
-
medical_tweets
Advertisement
